| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| COLES & BODOIN LLP | 2,635 | 0 | 0 | 2,635 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| VANGUARD DEVELOPED MARKETS | 519,256 | 629,862 |
| VANGUARD EMERGING MARKETS | 193,226 | 326,553 |
| MEDCO | 0 | 0 |
| VANGUARD 500 INDEX FUND | 691,394 | 826,496 |
| VANGUARD EUR STOCK INDEX | 987,400 | 1,024,583 |
| VANGUARD PAC STOCK INDEX | 846,966 | 813,486 |
| INCYTE CORP | 80,200 | 731,100 |
| ALKERMES PLC | 316,680 | 1,141,920 |
| Description | Amount |
|---|---|
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| MA FILING FEE | 125 | 0 | 0 | 125 |
| OFFICE | 39 | 0 | 0 | 39 |